Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-26

Clinical Trial Update: The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tranexamic acid to reduce perioperative blood loss in high-risk spine fusion surgery for curvature of the spine; study completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Northwestern University | Conditions: Curvature of Spine | Phase 2 | Status: COMPLETED | Results posted: 2021-01-26